Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9654538 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Pilot Immunotherapy Trial for Recurrent Malignant Gliomas
Condition: Malignant Glioma of Brain
Interventions: Drug: IGF-1R/AS ODN;   Device: biodiffusion chamber

Indicates status has not been verified in more than two years